Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone416-848-4156
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$49,523.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
VentriPoint Diagnostics (CVE:VPT) Frequently Asked Questions
What is VentriPoint Diagnostics' stock symbol?
VentriPoint Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VPT."
Has VentriPoint Diagnostics been receiving favorable news coverage?
Media headlines about VPT stock have been trending very positive on Wednesday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VentriPoint Diagnostics earned a daily sentiment score of 4.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for VentriPoint Diagnostics.
Who are some of VentriPoint Diagnostics' key competitors?
Some companies that are related to VentriPoint Diagnostics include GeneNews (GEN), SQI Diagnostics (SQD), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), Dorsavi (DVL), Cambridge Cognition (COG), Smiles Inclusive (SIL), Lifespot Health (LSH), Genedrive (GDR), Cryosite (CTE), 3D Signatures (DXD), Imaging Dynamics (IDL), Med Biogene (MBI) and BioMark Diagnostics (BUX).
What other stocks do shareholders of VentriPoint Diagnostics own?
Who are VentriPoint Diagnostics' key executives?
VentriPoint Diagnostics' management team includes the folowing people:
- Dr. George Adams, CEO & Director (Age 68)
- Mr. Desmond Hirson, Pres
- Ms. Ellen Briant, CFO & Corp. Sec.
- Dr. Alvira Macanovic Ph.D., VP of Devel. & Operations
- Ms. Jessica Naman, Marketing Mang.
How do I buy shares of VentriPoint Diagnostics?
Shares of VPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How big of a company is VentriPoint Diagnostics?
What is VentriPoint Diagnostics' official website?
How can I contact VentriPoint Diagnostics?
The company can be reached via phone at 416-848-4156.
MarketBeat Community Rating for VentriPoint Diagnostics (CVE VPT)
MarketBeat's community ratings are surveys of what our community members think about VentriPoint Diagnostics and other stocks. Vote "Outperform" if you believe VPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
